June 25, 2020
OXFORD, Miss. – The University of Mississippi School of Pharmacy recognized four of its faculty members for their excellence in and commitment to teaching, service and research during its virtual Faculty and Research Scientist Advancement.
“We are fortunate to have a team of faculty and research scientists that goes above and beyond,” said David D. Allen, dean of the School of Pharmacy. “It’s always a privilege for me to celebrate the work they do for our students, school and the profession with these awards.”
OXFORD, Miss. – University of Mississippi researchers, along with Woodcliff Skincare Solutions Inc., have been jointly issued a patent for Alasta, the main ingredient in a line of skin care products being sold under the brand name Sustainable Youth.
The primary ingredient in Alasta is derived from the aloe vera plant and is responsible for the clinically observed effects of enhanced skin firmness and wrinkle reduction. The composition contains aloeride, an immune-enhancing extract that was previously patented by the university and licensed to Woodcliff.
OXFORD, Miss. – Growing up in a small Texas town south of San Antonio, Michael A. Repka worked in his father’s pharmacy.
Frank Repka opened Center Pharmacy in Pleasanton in 1961, and Michael started working there when he was 11 – dusting bottles and shelves, restocking those dust-free shelves and performing various tasks for his father.
Read More: “Repka Presented University’s Top Research Award”
OXFORD, Miss. – Vitor H. Pomin, a professor in the University of Mississippi School of Pharmacy, has received a grant from the National Institute of Neurological Disorders and Stroke to investigate the molecular details and potential active compounds in the process of neuroregeneration.
Pomin, assistant professor of pharmacognosy, will seek to better understand the biochemical mechanisms that limit the ability of the nervous system to recover after damage.
OXFORD, Miss. – The University of Mississippi is home to a new center that aims to empower local communities to take charge of their community development, policy change and resilience building by using data and the arts.
The UM Community First Research Center for Wellbeing and Creative Achievement, or UM: CREW, will be a resource for Mississippi communities – from counties and cities to groups of citizens – to create, access, analyze and apply knowledge and data to improve community well-being and local and regional decision-making.
OXFORD, Miss. – The cannabis research program at the University of Mississippi School of Pharmacy has partnered with pharmaceutical company Emerald Bioscience Inc. to license two new drug technologies that may provide nonaddictive pain management, prevent blindness and alleviate the threat of irreversible vision loss from glaucoma and other eye diseases.
The two drug candidate formulations include a synthetic prodrug of tetrahydrocannabinol, commonly known as THC, the main psychoactive compound associated with marijuana, and a synthetic analog of cannabidiol another compound that is attracting widespread attention as a potential treatment for a variety of medical conditions. Both drug candidates are derivatives of the natural THC and CBD found in the cannabis plant.